US Patent Issued to Eli Lilly and Co. on Aug. 4 for "Extended time action acylated insulin compounds" (Indiana Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,314, issued on Aug. 4, was assigned to Eli Lilly and Co. (Indianapolis).

"Extended time action acylated insulin compounds" was invented by Seamus Patrick Brennan (Indianapolis), David Benjamin Flora (Greenfield, Ind.), Vladislav Kisselev (Carmel, Ind.), Wen Liu (Carmel, Ind.) and Francisco Alcides Valenzuela (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The presently described compounds relate to the treatment of Type I and/or Type II diabetes and/or hyperglycemia. More particularly, the described compounds relate to extended time action acylated insulin compounds that lower blood glucose, pharmaceutical compositions containing such co...